Spyre Therapeutics, Inc. SYRE
97.63 USD -3.83 (-3.77%)
Regular-session close
97.63 0.00 0.00%
After hours · Nov 19, 4:56 PM ET
97.49 Day range 103.50
23.01 52-week range 110.64
- YTD
- +198.02%
- 1 year
- +301.77%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -209.56M | -208.57M | -242.30M | -84.78M | -65.65M | |
| -155.20M | -208.02M | -338.79M | -83.81M | -65.80M | |
| -1.98 | -3.18 | -13.76 | -24.86 | -25.02 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 85.72M | 89.42M | 189.22M | 36.42M | 16.98M | |
| 777.78M | 608.48M | 341.86M | 71.14M | 109.93M | |
| 62.55M | 90.68M | 73.29M | 20.84M | 25.98M | |
| 715.24M | 517.80M | 184.02M | 50.30M | 83.94M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -169.25M | -157.41M | -99.91M | -80.14M | -53.72M | |
| -143.47M | -353.29M | -108.39M | 57.01M | -22.62M | |
| 309.02M | 410.91M | 361.08M | 42.68M | 1.39M | |
| -3.70M | -99.79M | 152.80M | 19.44M | -74.96M |
